Option Care Health (OPCH) to Release Earnings on Tuesday

Option Care Health (NASDAQ:OPCH) will post its quarterly earnings results before the market opens on Tuesday, April 23rd. Analysts expect Option Care Health to post earnings of $0.23 per share for the quarter. Option Care Health has set its FY 2024 guidance at EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Thursday, February 22nd. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.29 by $0.03. Option Care Health had a return on equity of 18.78% and a net margin of 6.21%. The firm had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.09 billion. During the same period last year, the company earned $0.26 earnings per share. Option Care Health’s revenue for the quarter was up 9.5% compared to the same quarter last year. On average, analysts expect Option Care Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Option Care Health Trading Up 0.6 %

Shares of NASDAQ:OPCH opened at $31.08 on Friday. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74. Option Care Health has a 12-month low of $24.23 and a 12-month high of $35.74. The business has a 50 day moving average of $32.27 and a two-hundred day moving average of $31.56. The company has a market capitalization of $5.40 billion, a PE ratio of 21.14, a PEG ratio of 1.76 and a beta of 1.22.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on OPCH. Barrington Research increased their price target on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “outperform” rating in a report on Friday, February 23rd. Jefferies Financial Group raised their target price on Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research report on Monday, March 4th.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of Option Care Health stock in a transaction on Monday, February 26th. The stock was acquired at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the acquisition, the director now directly owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Option Care Health

Hedge funds have recently made changes to their positions in the company. Toroso Investments LLC purchased a new stake in shares of Option Care Health in the third quarter valued at approximately $233,000. Wolverine Trading LLC purchased a new stake in shares of Option Care Health in the fourth quarter valued at approximately $222,000. Apollon Wealth Management LLC purchased a new stake in shares of Option Care Health in the fourth quarter valued at approximately $219,000. Schonfeld Strategic Advisors LLC purchased a new stake in shares of Option Care Health in the third quarter valued at approximately $214,000. Finally, Mercer Global Advisors Inc. ADV purchased a new stake in shares of Option Care Health in the first quarter valued at approximately $206,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.